Merotate S 1.5GM Inj.
Meropenem 1g + Sulbactam 500mg Injection
Enhanced Spectrum. Elevated Protection Against Resistance.
Meropenem + Sulbactam Injection combines the powerful carbapenem antibiotic Meropenem with the β-lactamase inhibitor Sulbactam, delivering a synergistic effect against a broad range of multidrug-resistant (MDR) bacterial pathogens. This combination is especially effective in managing complicated and hospital-acquired infections where resistance is a major concern.
Key Benefits:
Potent Broad-Spectrum Coverage:
Effective against Gram-positive, Gram-negative, anaerobic, and β-lactamase-producing organisms, including resistant strains.
Enhanced Activity Against MDR Pathogens:
Sulbactam inhibits β-lactamase enzymes, protecting Meropenem from enzymatic degradation and expanding its efficacy.
Ideal for Critical Infections:
Suitable for treating severe infections in ICU, post-surgical, and immunocompromised patients.
Reliable Tissue Penetration:
Ensures therapeutic levels in lungs, CSF, urinary tract, and intra-abdominal regions.
Indications:
Indicated for the treatment of serious and resistant infections such as:
Complicated intra-abdominal infections
Hospital-acquired and ventilator-associated pneumonia
Complicated urinary tract infections
Skin and soft tissue infections
Septicemia and bacteremia
Infections caused by ESBL-producing and other resistant organisms
Dosage & Administration:
Administered via intravenous infusion. Dose and duration as prescribed by the physician, based on infection severity and renal function.
Important Safety Information:
Use with caution in patients with a history of hypersensitivity to β-lactam antibiotics. Monitor renal function during prolonged therapy. Common side effects may include rash, diarrhea, nausea, and infusion site reactions.
Composition | Meropenem 1GM+Sulbactum 500MG Injection |
---|---|
Brand Name | MEROTATE S 1.5MG |
MRP | ₹3300 |
Packing | 20ML Vial+WFI+Tray |